Perguntar
Consultar
Descobrir
Calcular
Cadastre-se
Cadastre-se
Entrar
Entrar
Descobrir
EGFR-mutant NSCLC: Osimertinib initiation carries higher 6-month total healthcare costs vs 1st/2nd-gen TKIs - Notícias Vera Health